|
||||||||||
|
|
Medicine Research ›› 2020, Vol. 4 ›› Issue (4): 200017-200017.DOI: 10.21127/yaoyimr20200017
所属专题: Anticancer Agents
Xiaodi Li,†,a,d Rui Liu,†,c Ping Wang,*,b,c and Jun Zhu*,b,c
Xiaodi Li,†,a,d Rui Liu,†,c Ping Wang,*,b,c and Jun Zhu*,b,c
摘要: This study explores the inhibitory effect of triptolide on ovarian cancer cells through in vitro cell and in vivo animal model experiments. We use the CCK-8 survival rate experiment to determine appropriate concentration of triptolide and the type of cell line including SF9, HEK293, A2780 and Skov-3. Furthermore, the cell invasion and migration of A2780 and Skov-3 cells shows that triptolide had a strong inhibitory effect on ovarian cancer cell line. In addition, flow cytometry is used to detect the apoptosis and cycle of A2780 cells. The results prove that the proliferation of ovarian cancer cell lines is significantly inhibited by triptolide at a 200 nmol/L concentration. Finally, in vivo animal model shows a strong inhibitory effect of triptolide with a 200 nmol/L concentration on ovarian cancer. However, HE staining of animal liver, kidney and ovarian tissue section reveals that there is a stronger effect of 200 nmol/L triptolide on the damage of living organs coming from its toxicity. The result offers a chance for reasonable safety use of triptolide.
中图分类号:
版权所有 © 《Medicine Research》编辑部 本系统由北京玛格泰克科技发展有限公司设计开发 技术支持:support@magtech.com.cn 总访问量: |